Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Sep 1;25(1):672.
doi: 10.1186/s12887-025-06020-w.

Splenic sequestration crisis in children with sickle cell disease in the Eastern region of Saudi Arabia

Affiliations

Splenic sequestration crisis in children with sickle cell disease in the Eastern region of Saudi Arabia

Abdalla Mohamed Zayed et al. BMC Pediatr. .

Abstract

Background: Acute splenic sequestration crisis (ASSC) is a potentially life-threatening complication of sickle cell disease (SCD). Previous studies have shown that patients who carry the African sickle gene haplotypes have more severe SCD than those with the Asian haplotype. In Saudi Arabia (SA), people living in the eastern region are known to carry the Asian haplotype, whereas patients in the southwestern (SW) region are more likely to carry the African haplotype. The aim of this study was to determine the prevalence and clinical features of ASSC among children with SCD who originated from both regions but were living in the same environment in the eastern region of that country.

Methods: This retrospective cohort study included 340 children with SCD who visited our hospital from 2010 to 2020. The collected clinical data of patients with ASSC were compared between two groups of patients: eastern and SW children.

Results: Over the study period, out of 340 children with SCD, 50 patients had ASSC, with a male/female ratio of 2.1:1. There were 38 children from the SW region and 12 from the eastern region. The overall prevalence of ASSC was 14.7%, with no significant difference between the two groups (p = .56). The SW group was diagnosed with SCD at a younger age than their eastern peers [median (IQR)]: 8.5 (6-11) vs. 30.5 (24-36) months; p < .001. The median (IQR) steady state hemoglobin (HB) level in the SW group was significantly lower than that in the eastern group [8 (7.5-9) vs. 9 (8-10) gm/dL]; p = .001]. During the first instance of episode of ASSC, there was a significant difference between the SW group and the eastern group in the following parameters [median (IQR)]: age [25 (12-48) v. 72 (39-134) months, p = .001], HB [5.1 (4.4-5.9) v. 6.1 (5.9-6.4) gm/dL, p = .01], splenic size on admission [5.5 (3-8) v. 8 (6-9.5) cm, p = .01], and splenic size upon discharge [3 (2-5) v. 5 (3.5-5.5) cm below the costal margin, p = .02]. The SW group had a significantly greater number of recurrences than did the eastern group [3.5 (2-6) v. 2 (1.5-2.5); p = .03].

Conclusions: The overall prevalence of ASSC among SCD children in the eastern region of SA was 14.7%, and there was no significant difference between the eastern and SW groups. Despite living in the same environment in the eastern region, children from southwestern SA experienced more severe ASSC manifestations than their eastern peers.

Trial registration: Not.

Keywords: Children; Eastern region; Saudi; Sickle cell disease; Splenic sequestration.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethical approval and consent to participate: This study was conducted in accordance with good clinical practice and the declaration of Helsinki. The study received scientific and ethical approval from the Armed Forces Hospitals Eastern Province Institutional Review Board (IRB): IRB (Protocol No. AFHER-IRB-2021-008). A waiver of informed consent was granted due to the retrospective nature of the study. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Steady-state HB
Fig. 2
Fig. 2
Age at the 1 st episode of SSC
Fig. 3
Fig. 3
HB during the 1 st episode of SSC
Fig. 4
Fig. 4
Splenic size on admission during the 1 st episode of SSC
Fig. 5
Fig. 5
Splenic size upon discharge during the 1 st episode of SSC
Fig. 6
Fig. 6
Number of SSC recurrences

Similar articles

References

    1. Namazzi R, John CC, Conroy AL, Datta D, Ware R, Hume H, et al. Development of research capacity in sickle cell anemia in Uganda: impact of collaborations. Blood Adv. 2017;1:11–3.
    1. Allali S, Galacteros F, Oevermann L, Cannas G, Joseph L, Loko G, et al. Hydroxyurea is associated with later onset of acute splenic sequestration crisis in sickle cell disease: lessons from the European sickle cell disease Cohort-Hydroxyurea (ESCORT-HU) study. Am J Hematol. 2024;99:555–61. - PubMed
    1. Kane I, Kumar A, Atalla E, Nagalli S. Splenic sequestration crisis. Treasure Island (FL): StatPearls Publishing; 2025. - PubMed
    1. Khaled MB, Ouederni M, Mankai Y, Rekaya S, Ben Fraj I, Dhouib N, et al. Prevalence and predictive factors of Splenic sequestration crisis among 423 pediatric patients with sickle cell disease in Tunisia. Blood Cells Mol Dis. 2020;80: 102374. - PubMed
    1. Serjeant G, Mason K, Hambleton I, Serjeant B. Acute splenic sequestration in hbss: observations from the Jamaican birth cohort. Arch Dis Child. 2024;109:100–5. - PubMed

LinkOut - more resources